Seeking men and women who have been diagnosed with schizophrenia or schizoaffective disorder and a substance use disorder for a study of an anti-psychotic medication to see it helps reduce substance cravings.
We are studying whether an FDA approved anti-psychotic can help reduce substance use in individuals diagnosed with schizophrenia or schizoaffective disorder. Some recent studies have shown that drugs similar to brexpiprazole can help reduce substance craving and have been used with patients who have schizophrenia.
What we're hoping for
Evaluate whether the investigational drug is safe and effective for reducing substance use in people diagnosed with schizophrenia or schizoaffective disorder.
ClinicalTrials.gov Identifier: NCT03526354